Seema Gulia

[Seema Gulia @seemagulia1]

Incredible !!
Congratulations to the entire CAR T team 🎉

[Gaurav Narula MD @DrGauravNarula]

Break from #SIOP2023ambassador for all the messages flowing through!
🙏🙏
Met @purwarrahul2 in 30/5/15 1st 🇮🇳 CAR T 4/6/21 & approved 12/10/23
What a journey!
Happy beyond words
Grateful to so many 🙏🙏
@TataMemorial @ACTREC_TMC @hkJain_kmc @NiraliShahMD @AlbeenaDr @VidyaVedham

[Seema Gulia @seemagulia1]

Be selective in subjecting patients to Secondary Cytoreduction !
Incomplete surgery is detrimental. https://t.co/nw31g0UZCl

[Seema Gulia @seemagulia1]

Indeed a special moment and very well deserved, @DrGauravNarula !
Heartiest congratulations🎉

[Gaurav Narula MD @DrGauravNarula]

A special moment!
Felicitated by legendary Dr Advani under whom I, like many, started Oncology journey, revered teachers Drs Sudeep Gupta & Reena Nair, legends in the audience
Honored to have had the opportunity to walk in your footsteps🙏🙏
Thanks kind words ⁦⁦@bagalbp⁩

[Seema Gulia @seemagulia1]

Congratulations @RimaPathak1 and @RajivSarin5 !!

[Rima Pathak MD @RimaPathak1]

Quite excited that our work on the Largest #RealWorldData of RNI in #breastcancer using #UHFRT got selected for an ORAL presentation at #ASTRO2023. Lots of hard work by all our @TMC_BreastDMG especially @RajivSarin5, Tabassum W, @drrevathyk @khandavalliashu who made it possible!

[Seema Gulia @seemagulia1]

Indeed it is a proud moment ! More power to you @ManjuSengar7

[bhawna sirohi @SirohiBhawna]

So proud of the first woman head of medical oncology ever @ManjuSengar7 .. so proud of you manju , expecting great things .. !! @TataMemorial @ACTREC_TMC .. 👏dr badwe ! @Shrikhande_SV @cspramesh we need a female medical director now in collegium :) @seemagulia1 @VanitaNoronha

[Seema Gulia @seemagulia1]

Congratulations Vijay and team!

[Dr (Prof). Vijay Patil @DrVijayPatil11]

Phase III Randomized Trial for Use of Docetaxel in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation. @VanitaNoronha @Amolpatel_dr @Nandinimenon18 @DrEzraCohen @JCO_ASCO @HHKhar @TataMemorial @DrHaddadRobert https://t.co/XcE2tt8FRV

[Seema Gulia @seemagulia1]

The long time debate on the use of platinum in TNBC is finally settled ! Congratulations @ACTREC_TMC, @TataMemorial, entire breast DMG for this landmark trial. Platinum improves survival in premenopausal TNBC.

[Seema Gulia @seemagulia1]

@drvineetgovinda @ACTREC_TMC @BanerjeeSusana @SuyogCancer @ESMO_Open Here it is .. https://t.co/tjFgdGJJdP

[Seema Gulia @seemagulia1]

Updated IPD meta-analysis (including ATHENA-MONO data) on efficacy of maintenance PARP inhibitors in newly diagnosed advanced epithelial ovarian cancers,did not show substantial benefit of PARP inhibitors in HRD negative tumors @ACTREC_TMC @BanerjeeSusana @SuyogCancer @ESMO_Open

[TMC Breast DMG @TMC_BreastDMG]

Watch this space … this year the breast cancer DMG launches the breast awareness campaign…Hamara wala pink. Dedicated to our patients, our women of substance. @nitaSnair @RimaPathak1 @JyotiBajpai01 @DrVaniParmar @Shalakajoshi15 @RajivSarin5

[Seema Gulia @seemagulia1]

Choosing wisely is the way forward! @ACTREC-TMC @ TataMemorial @BanerjeeSusana @SuyogCancer

[ACTREC-TMC @ACTREC_TMC]

@seemagulia1 @TataMemorial publish the only IPD metaanalysis PARP-inhibitors first-line ovarian cancer! Highly impactful results, clear benefit BRCA-mut or HRD-pos pts, but NOT in BRCA-wt/HRD-neg pts! @jamecancerdoc @AnaOaknin @myESMO @ASCOPost @sujithonco https://t.co/eXGgl26gAt

[Seema Gulia @seemagulia1]

First line maintenance PARPi in ovarian cancer improves PFS ✅ in BRCA mutant and HRD positive patients and NOT in HRD negatives ❌.
Choosing wisely is the way forward !https://t.co/X9ZW4FunDn @cspramesh @ACTREC_TMC @ICMRDELHI

[Rima Pathak MD @RimaPathak1]

I laughed till I had tears in my eyes and the lady sitting next to me the bus surely thought I had gone bonkers 🤣

[ACTREC-TMC @ACTREC_TMC]

Many congratulations to @VedangMurthy & colleagues! Practice defining study!
https://t.co/i3RgIhBEZY

[Seema Gulia @seemagulia1]

Congratulations Dr Gupta !!

[ACTREC-TMC @ACTREC_TMC]

We congratulate Dr Sudeep Gupta, Director @ACTREC_TMC , on being conferred the Urmil B K Kapoor Oration 2020, by @aiims_nd ! The Oration was delivered today and can be accessed at https://t.co/3iy2Za4Eoi
@TataMemorial @AnuragAgrawalMD

[Tata Memorial Hospital @TataMemorial]

In India, 1 in 28 women will develop breast cancer during her lifetime. This #BreastCancerAwarenessMonth Dr Sudeep Gupta, Director @ACTREC_TMC tells us how we can reduce the risk of #breastcancer. @TataMemorial

[mridulachakraborty.🇮🇳 @mridula2c]

Marin Drive last evening- Bombay.
Wonder who the photographer is!!!

[ACTREC-TMC @ACTREC_TMC]

Concerning cardiac effects of #COVID ! Almost 60% patients, many mild disease, had heart inflammation on MRI after recovery! Even if very small fraction have clinical problems, will be large no., given millions infected! Need for vigilance! @JAMACardio
https://t.co/LJutrUU7Bq

[ACTREC-TMC @ACTREC_TMC]

Dr Sudhir Nair & colleagues from @TataMemorial @ACTREC_TMC provide compelling evidence of effectiveness & accuracy of symptom-based telephonic follow-up in cancer patients in @JAMAOto ! Hugely important at all times but especially during #COVID
https://t.co/bC6RSZxwt2

[Seema Gulia @seemagulia1]

@oncology_bg @SirohiBhawna @TataMemorial @JAMANetworkOpen @ACTREC_TMC @ASCO @CancerGridIndia @DAEIndia @ASCOPost @IJMPOofficial @MoHFW_INDIA @myESMO @OncoAlert @DrHBurstein @SusannahStanwa1 @GlobalOncPod @womeninGH @LGCW2020 Thankyou @oncology_bg Dr.Gyawali. One year is superior to shorter duration and we did analysed for superiority in our paper. But less than one year is non inferior as the upper bound of 95% CI of HR (1.14 (1.03- 1.25) for DFS, did not cross the non inferiority margin of 1.3.

[Seema Gulia @seemagulia1]

A Landmark study from @TataMemorial #Meta-analysis suggesting that less than one year of #Trastuzumab is not inferior to a year long therapy! https://t.co/PfwEOcNgpp @JAMANetworkOpen @ACTREC_TMC @ASCO @CancerGridIndia @DAEIndia @ASCOPost @IJMPOofficial @MoHFW_INDIA @myESMO